Literature DB >> 7939966

Demographic factors associated with extreme non-compliance in schizophrenia.

W Sellwood1, N Tarrier.   

Abstract

Having identified total non-compliance with neuroleptic medication as a major problem in a significant proportion of schizophrenic patients, an analysis of potentially important demographic factors associated with this problem was carried out. The in-patient records of 256 schizophrenic patients were examined with reference to ethnicity, gender, age, number of admissions and amount of time spent in hospital over a 3-year period. Non-compliant patients differed from those who were at least partially compliant in that they were more likely to be Afro-Caribbean and male, have shorter stays in hospital and have more admissions. There was no difference between these groups in terms of age, although certain subgroups exhibited some age differences. Logistic regression analyses revealed that gender and ethnicity were significant predictors of extreme non-compliance, to the extent that in male Afro-Caribbeans there was a 31% chance that prophylactic medication would be completely refused. The implications of these results and methodological issues are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939966     DOI: 10.1007/bf00802014

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  28 in total

1.  Factors affecting compliance with depot injection treatment in the community.

Authors:  S Tunnicliffe; G Harrison; P J Standen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-10       Impact factor: 4.328

Review 2.  [Adherence to neuroleptic treatment of schizophrenic patients].

Authors:  I Blondiaux; M Alagille; D Ginestet
Journal:  Encephale       Date:  1988 Nov-Dec       Impact factor: 1.291

3.  Underprivileged areas: validation and distribution of scores.

Authors:  B Jarman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

4.  Why do schizophrenic patients refuse to take their drugs?

Authors:  T Van Putten
Journal:  Arch Gen Psychiatry       Date:  1974-07

Review 5.  The burden of care: the impact of functional psychiatric illness on the patient's family.

Authors:  G Fadden; P Bebbington; L Kuipers
Journal:  Br J Psychiatry       Date:  1987-03       Impact factor: 9.319

6.  Clinical characteristics of hospitalized psychotic patients who refuse antipsychotic drug therapy.

Authors:  J M Zito; W W Routt; J E Mitchell; J L Roerig
Journal:  Am J Psychiatry       Date:  1985-07       Impact factor: 18.112

7.  The influence of ethnicity and family structure on relapse in first-episode schizophrenia. A comparison of Asian, Afro-Caribbean, and white patients.

Authors:  M Birchwood; R Cochrane; F Macmillan; S Copestake; J Kucharska; M Carriss
Journal:  Br J Psychiatry       Date:  1992-12       Impact factor: 9.319

8.  Service and patient predictors of continuation in clinic-based treatment.

Authors:  N Atwood; J C Beck
Journal:  Hosp Community Psychiatry       Date:  1985-08

9.  A prospective, multicenter study of patients' refusal of antipsychotic medication.

Authors:  S K Hoge; P S Appelbaum; T Lawlor; J C Beck; R Litman; A Greer; T G Gutheil; E Kaplan
Journal:  Arch Gen Psychiatry       Date:  1990-10

10.  Important issues in the drug treatment of schizophrenia.

Authors:  J M Davis; C B Schaffer; G A Killian; C Kinard; C Chan
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

View more
  12 in total

1.  Adequacy of treatment for serious mental illness in the United States.

Authors:  Philip S Wang; Olga Demler; Ronald C Kessler
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

2.  Determinants of anti-psychotic medication compliance in a multicultural population.

Authors:  S J Ziguras; S Klimidis; T J Lambert; A C Jackson
Journal:  Community Ment Health J       Date:  2001-06

3.  Patterns of health services utilization by recent immigrants.

Authors:  Nicole Leduc; Michelle Proulx
Journal:  J Immigr Health       Date:  2004-01

Review 4.  Race and mental health: there is more to race than racism.

Authors:  Swaran P Singh; Tom Burns
Journal:  BMJ       Date:  2006-09-23

5.  Compliance therapy in psychotic patients: randomised controlled trial.

Authors:  R Kemp; P Hayward; G Applewhaite; B Everitt; A David
Journal:  BMJ       Date:  1996-02-10

Review 6.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

7.  Compliance therapy: a randomised controlled trial in schizophrenia.

Authors:  Colin O'Donnell; Gary Donohoe; Louise Sharkey; Nicholas Owens; Maria Migone; Raewynn Harries; Anthony Kinsella; Conall Larkin; Eadbhard O'Callaghan
Journal:  BMJ       Date:  2003-10-11

8.  Age of onset of life-time mental disorders and treatment contact.

Authors:  Janhavi Ajit Vaingankar; Gurpreet Rekhi; Mythily Subramaniam; Edimansyah Abdin; Siow Ann Chong
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-18       Impact factor: 4.328

Review 9.  Disengagement from mental health services. A literature review.

Authors:  Aileen O'Brien; Rana Fahmy; Swaran P Singh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-26       Impact factor: 4.328

10.  Involuntary admission may support treatment outcome and motivation in patients receiving assertive community treatment.

Authors:  Hans Erik Kortrijk; A B P Staring; A W B van Baars; C L Mulder
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-02       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.